Project Details
Projekt Print View

Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency

Subject Area Hematology, Oncology
Immunology
Term from 2018 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 398018062
 
Final Report Year 2024

Final Report Abstract

Hematopoietic stem and progenitor cells were gene edited and gene correction assessed molecularly and through the gained capacity to give rise to cells of the lymphoid lineage. T cell development has been shown in in vitro culture systems and, to a lower extend, in vivo. Together, while proof of principle of gene editing of human HSPCs from primary immune deficient patients has been achieved, the efficiency of human HSPC culture and targeting conditions should be improved for further studies.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung